glp-1 and eye disease Receptor Agonists vision risk Emerging Concerns: GLP-1 Modulators and

Ex-4 treatment upregulates the expression of the proteins critical for mitochondrial biogenesis, including peroxisome proliferator-activated receptor- coactivator-1 (PGC-1), nuclear respiratory factor-1 (NRF-1), and transcription factor a, mitochondrial (Tfam)

Open communication about expectations, concerns, and practical considerations is essential for developing an appropriate long-term strategy

Those findings were largely ignored - until the emergence of second-generation GLP-1 drugs like semaglutide and tirzepatide

How to transition a patient with type 2 diabetes mellitus (T2DM) from daily glipizide (sulfonylurea) to a Glucagon-Like Peptide-1 (GLP-1) receptor agonist?